UK haemophilia reference centre directors sent a circular letter to all haemophilia centres with recommendations on choice on therapeutic products for the treatment of non-inhibitor patients with Haemophilia A, Haemophilia B or von Willebrand's Disease.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation